Frameshift Mutations in Genes Encoding PBP3 and PBP4 Trigger an Unusual, Extreme β-Lactam Resistance Phenotype in <i>Burkholderia multivorans</i>
In our curated panel of <i>Burkholderia cepacia</i> complex isolates, <i>Burkholderia multivorans</i> strain AU28442 was unusually highly β-lactam resistant. To explore the molecular mechanisms leading to this phenotype, we performed whole genome sequencing (WGS) and microbiological and biochemical assays. WGS analysis revealed that strain AU28442 produced two β-lactamases, AmpC22 and a novel PenA-like β-lactamase denominated PenA39. Additionally, the strain presented frame-shift mutations in the genes encoding penicillin binding proteins 3 (PBP3) and 4 (PBP4). The antibiotic susceptibilities of the parent AU28442 strain carrying <i>bla</i><sub>PenA39</sub> vs the isogenic <i>E. coli</i>strain producing <i>bla</i><sub>PenA39</sub> were discrepant with ceftazidime MICs of >512 and 1 μg/mL, respectively. Accordingly, PenA39 was found to poorly hydrolyze β-lactams with <i>k</i><sub>cat</sub> values of ≤8.8 s<sup>-1</sup>. An overlay of the crystal structure of PenA39 with PenA1 revealed a shift in the SDN loop in the variant, which may affect the catalytic efficiency of PenA39 toward substrates and inhibitors. Moreover, microscopic examination of AU28442 revealed shortened rod-shaped cells compared to <i>B. multivorans</i>ATCC 17616, which carries a full complement of intact PBPs. Further complementation assays confirmed that the loss of PBP3 and PBP4 was the main factor contributing to the high-level β-lactam resistance observed in <i>B. multivorans</i>AU28442. This information allowed us to revert susceptibility by pairing a potent β-lactamase inhibitor with a β-lactam with promiscuous PBP binding. This detailed characterization of <i>B. multivorans</i>provides an illustration of the myriad ways in which bacteria under antibiotic selection can develop resistance and demonstrates a mechanism to overcome it.
Authors
- Krisztina M. Papp‐Wallace (ORCID: https://orcid.org/0000-0002-9976-7898)
- John J. LiPuma (ORCID: https://orcid.org/0000-0003-4033-7794)
- Scott A. Becka
- Tyuji Hoshino (ORCID: https://orcid.org/0000-0003-4705-4412)
- Elise T. Zeiser
- María F. Mojica (ORCID: https://orcid.org/0000-0002-1380-9824)
- Michiyoshi Nukaga (ORCID: https://orcid.org/0000-0002-3508-3390)
Institutions
- Chiba University (JP)
- University of Michigan (US)
- Department of Disease Control (TH)
- VA Northeast Ohio Healthcare System (US)
- Center for Non-Communicable Diseases (PK)
- Case Western Reserve University (US)
- Josai International University (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- ACS Infectious Diseases
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1021/acsinfecdis.4c00330
- Citations
- 3
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.51
Funders
- U.S. Department of Veterans Affairs
- Cystic Fibrosis Foundation
- Japan Society for the Promotion of Science